Sarepta Therapeutics sees setback in Eteplirsen drug application By: MarketWatch October 27, 2014 at 07:59 AM EDT Company is planning a new drug application for its MS treatment by mid-2015. Read More >> Related Stocks: Sarepta Therapeutics